Company profile for Novelion Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Novelion Therapeutics, we seek to develop new standards of care for individuals living with rare diseases. We depend on the commitment, ideas and actions of each individual employee to advance patient care and a create sustainable future for our organization. Drawing upon available data and the diverse perspectives of individuals and functions, we encourage a free exchange of ideas. We are a learning organization and work w...
At Novelion Therapeutics, we seek to develop new standards of care for individuals living with rare diseases. We depend on the commitment, ideas and actions of each individual employee to advance patient care and a create sustainable future for our organization. Drawing upon available data and the diverse perspectives of individuals and functions, we encourage a free exchange of ideas. We are a learning organization and work with urgency, an entrepreneurial mindset that challenges the status quo and efficient operations. We strive to be leaders by making sound decisions with all of our stakeholders’ interests in mind.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
1800 - 510 West Georgia Street Vancouver, BC V6B 0M3
Telephone
Telephone
617-500-7867
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/03/10/2624915/0/en/Novelion-Announces-Completion-of-Plan-of-Liquidation-and-Distribution-and-its-Voluntary-Dissolution.html

GLOBENEWSWIRE
10 Mar 2023

https://www.globenewswire.com/news-release/2022/03/28/2411454/0/en/Novelion-Announces-Date-of-Final-Distribution-to-Registered-Shareholders.html

GLOBENEWSWIRE
28 Mar 2022

https://www.globenewswire.com/news-release/2021/01/26/2164645/0/en/Novelion-Provides-Update-on-Interim-Distribution-to-Registered-Shareholders.html#:~:text=Novelion%20Provides%20Update%20on%20Interim%20Distribution%20to%20Registered%20Shareholders,-Email%20Print%20Friendly&text=January%2026%2C%202021%2014%3A49,Source%3A%20Novelion%20Therapeutics%2C%20Inc.&text=Novelion%20will%20be%20taking%20steps,authorizations%20in%20such%20Court%20Order.

GLOBENEWSWIRE
26 Jan 2021

https://endpts.com/coming-out-of-chapter-11-aegerion-jumps-into-welcome-arms-of-irish-pharma-with-big-plans-fresh-60m-for-its-drugs/

Amber Tong ENDPTS
25 Sep 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty